Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Other(3)

Detailed Status

unknown3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 43 (100.0%)

Trials by Status

unknown3100%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_4

Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris

NCT04661709
unknownphase_4

Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization

NCT03072082
unknownphase_4

Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization

NCT03072121

Clinical Trials (3)

Showing 3 of 3 trials
NCT04661709Phase 4

Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris

Unknown
NCT03072082Phase 4

Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization

Unknown
NCT03072121Phase 4

Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3